Patient characteristics at baseline
| Adherence rate (%) | |||
| Patients (n) | Median | IQR | |
| Overall | 6424 | 50.0 | 25.0–71.4 |
| Age | |||
| 18–44 | 213 | 33.3 | 0.0–60.0 |
| 45–54 | 690 | 40.0 | 20.0–63.4 |
| 55–64 | 1642 | 50.0 | 25.0–69.2 |
| 65+ | 3879 | 50.0 | 25.0–75.0 |
| Gender | |||
| Female | 3014 | 50.0 | 25.0–71.4 |
| Male | 3410 | 50.0 | 25.0–71.4 |
| Socioeconomic status | |||
| 1 (most disadvantaged) | 904 | 50.0 | 25.0–70.0 |
| 2 | 670 | 42.9 | 20.0–66.7 |
| 3 | 1438 | 50.0 | 25.0–75.0 |
| 4 | 1256 | 50.0 | 25.0–71.4 |
| 5 (most advantaged) | 2156 | 50.0 | 25.0–71.4 |
| Remoteness | |||
| Major cities | 5143 | 50.0 | 25.0–71.4 |
| Regional/remote | 1281 | 53.8 | 28.6–75.0 |
| Medication | |||
| Insulin | 890 | 50.0 | 28.6–72.0 |
| Oral agents only | 3734 | 50.0 | 25.0–71.4 |
| No medication | 1800 | 50.0 | 20.0–70.0 |